Effect of Proton Pump Inhibitors on CF Pulmonary Exacerbations

Completed · Phase 2 · Has a placebo group

Conditions studied: Cystic Fibrosis

In brief

Gastroesophageal reflux disease (GERD) is a common problem in cystic fibrosis (CF). It may lead to worsening lung function and more respiratory infections for a person with CF. This study will look at treating GERD with a medication, esomeprazole. The medication stops stomach acid from being made. The study will see if there are fewer respiratory infections and improved lung function in patients with CF when taking esomeprazole.

Key facts

Study ID
NCT01983774
Run by
Columbia University
People needed
21
Starts
2008-02-01
Expected to finish
2011-08-01
Last updated by the study team
2022-02-17

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.